Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/22569
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJhaumeer-Laulloo, S-
dc.contributor.authorWitvrouw, M-
dc.date.accessioned2013-10-23T09:51:24Z-
dc.date.available2013-10-23T09:51:24Z-
dc.date.issued2000-11-
dc.identifier.issn0975-0983(Online); 0376-4699(Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/22569-
dc.description842-846en_US
dc.description.abstractA series of macrocyclic dilactams containing a disulphide bridge has been synthesized by the condensation of 2,2'-dithiodibenzoyl chloride with diamines. These compounds have been evaluated for their ability to inhibit reverse transcriptase (RT) of the human immunodeficiency virus HIV-1 (IIIB) and HIV-2 (ROD) in acutely infected MT-4 cells. The anti-HIV activity of these compounds depends on the ring size and also on the diamino counterpart. The dilactams with 12-membered rings 1 and 5 were found to be the most potent. The active analogues 1 and 5 inhibit the replication of HIV-1 (IIIB) and HIV-2 (ROD) with an EC50 between 1.2 to 4.4 μg/mL. The dilactam 7 shows comparable activity in C8166 cells.en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJC-B Vol.39B(11) [November 2000]en_US
dc.titleSynthesis and anti-HIV activity of novel macrocyclic benzamides with a disulphide bridgeen_US
dc.typeArticleen_US
Appears in Collections:IJC-B Vol.39B(11) [November 2000]

Files in This Item:
File Description SizeFormat 
IJCB 39B(11) 842-846.pdf1.18 MBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.